Clinical, Hormonal and Metabolic Parameters in Women With PCOS Using Different Combined Oral Contraceptives (Containing Chlormadinone Acetate Versus Drospirenone)

    October 2019 in “ Journal of Endocrinological Investigation ”
    Agnieszka Podfigurna, Błażej Męczekalski, Felice Petraglia, Stefano Luisi
    Studysummary This study reported that both drospirenone and chlormadinone acetate oral contraceptives had similar beneficial effects on clinical, metabolic, and hormonal parameters in women with polycystic ovary syndrome over six months.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Dermatologic Manifestations of Endocrine Disorders Translational pediatrics · 2017
    2. Hyperandrogenemia in Women with Polycystic Ovary Syndrome: Prevalence, Characteristics, and Association with Body Mass Index Hormone Molecular Biology and Clinical Investigation · 2017
    3. Comparison of Two Contraceptive Pills Containing Drospirenone and 20 μg or 30 μg Ethinyl Estradiol for Polycystic Ovary Syndrome International Journal of Gynecology & Obstetrics · 2015
    4. Mood Disorders and Quality of Life in Polycystic Ovary Syndrome Gynecological Endocrinology · 2015
    5. Treatment Options for Polycystic Ovary Syndrome International journal of women's health · 2011
    6. Visually Scoring Hirsutism Human reproduction update · 2009
    7. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome Fertility and Sterility · 2004
    8. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS) Human Reproduction · 2003